B-Balloon

B-Balloon Ltd. is an Israeli medical device company that specialized in the development of advanced stents and stent delivery systems (SDS) for interventional cardiology and vascular surgery. The company's core technology was designed to treat complex vascular conditions, specifically ostial and bifurcation lesions in coronary and peripheral arteries, which represent significant challenges in percutaneous coronary intervention. Founded in 2003 and incubated by Peregrine Ventures, B-Balloon's innovations aimed to improve the precision and safety of stent placement in difficult anatomical locations. In 2008, the company was acquired by Medical Ventures Corp., which subsequently rebranded as Neovasc Inc. to integrate B-Balloon's vascular portfolio into its broader cardiovascular platform. The acquisition was part of a strategic move to expand the parent company's pipeline of vascular therapies. B-Balloon's technology contributed to the development of specialized solutions for heart and vascular diseases.